HIM
MRK icon

Hanlon Investment Management’s Merck MRK Stock Holding History

Hanlon Investment Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
2,389
+203
+9% +$23.4K 0.16% 179
2025
Q4 		$230K Buy
+2,186
New +$205K 0.13% 188
2025
Q1 		– Sell
-4,601
Closed -$458K – 188
2024
Q4 		$458K Buy
4,601
+540
+13% +$55.7K 0.12% 114
2024
Q3 		$461K Buy
4,061
+164
+4% +$19.5K 0.13% 113
2024
Q2 		$482K Buy
3,897
+438
+13% +$56.4K 0.14% 94
2024
Q1 		$456K Buy
3,459
+271
+9% +$33.4K 0.14% 94
2023
Q4 		$348K Sell
3,188
-256
-7% -$26.6K 0.11% 100
2023
Q3 		$355K Buy
3,444
+488
+17% +$52.6K 0.11% 108
2023
Q2 		$341K Buy
2,956
+400
+16% +$45.4K 0.1% 109
2023
Q1 		$272K Buy
2,556
+182
+8% +$19.6K 0.08% 112
2022
Q4 		$263K Sell
2,374
-47
-2% -$4.8K 0.09% 104
2022
Q3 		$208K Hold
2,421
– – 0.08% 99
2022
Q2 		$221K Buy
+2,421
New +$215K 0.05% 108
2021
Q3 		– Sell
-2,636
Closed -$205K – 138
2021
Q2 		$205K Sell
2,636
-123
-4% -$9.15K 0.04% 130
2021
Q1 		$203K Buy
2,759
+2
+0.1% +$148 0.04% 126
2020
Q4 		$215K Buy
2,757
+2
+0.1% +$153 0.05% 113
2020
Q3 		$218K Buy
2,755
+3
+0.1% +$235 0.07% 100
2020
Q2 		$203K Sell
2,752
-3,433
-56% -$258K 0.06% 105
2020
Q1 		$454K Buy
6,185
+3,416
+123% +$268K 0.29% 53
2019
Q4 		$240K Buy
2,769
+24
+0.9% +$1.97K 0.05% 97
2019
Q3 		$220K Sell
2,745
-2,741
-50% -$220K 0.06% 79
2019
Q2 		$439K Hold
5,486
– – 0.03% 86
2019
Q1 		$435K Buy
+5,486
New +$410K 0.05% 78
2017
Q2 		– Sell
-44,695
Closed -$2.71M – 92
2017
Q1 		$2.71M Buy
+44,695
New +$2.71M 0.34% 48
2016
Q3 		– Sell
-92,333
Closed -$5.08M – 89
2016
Q2 		$5.08M Buy
+92,333
New +$4.91M 0.44% 33
2016
Q1 		– Sell
-78,770
Closed -$3.97M – 99
2015
Q4 		$3.97M Buy
+78,770
New +$3.97M 0.38% 34

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hanlon Investment Management's MRK Position: Q1 2026 in Review

Hanlon Investment Management increased its Merck (MRK) stake by 9.3% in Q1 2026, buying an estimated $23.4K and bringing the position to 2,389 shares worth $287K. The position accounts for 0.16% of the portfolio, ranked #179.

Hanlon Investment Management first reported a position in MRK in Q4 2015 and has held it in 26 quarters since. The position peaked at $5.08M in Q2 2016. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hanlon Investment Management held 2,389 shares of Merck worth $287K as of Q1 2026.
  • Hanlon Investment Management bought 203 Merck shares in Q1 2026, an estimated $23.4K.
  • Merck made up 0.16% of Hanlon Investment Management's portfolio in Q1 2026, its #179 holding.
  • Hanlon Investment Management first reported a position in Merck in Q4 2015 and has held it in 26 quarters since.
  • Hanlon Investment Management's Merck position peaked at $5.08M in Q2 2016.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hanlon Investment Management's 13F filing for Q1 2026, filed 12 May 2026.